CoChat

Identification of Cardiometabolic Protein Biomarkers for Acute Myocardial Infarction Using Olink Proteomics

Open access

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Background: Acute myocardial infarction (AMI) is a critical cardiovascular event characterized by sudden coronary blood flow interruption, leading to myocardial ischemia and necrosis. Despite advances in acute therapeutic measures, understanding the metabolic damage related to AMI, particularly through specific protein expressions, remains limited. This study utilized Olink cardiovascular metabolomics technology to explore cardiovascular metabolism-related protein biomarkers associated with AMI, aiming to address the clinical need for early diagnosis and targeted therapy. Methods: This study utilized Olink cardiovascular metabolomics technology to analyze 92 cardiovascular metabolism-related proteins in coronary blood samples from 20 AMI patients and 10 healthy controls. Differentially expressed proteins were identified using statistical t-tests, followed by functional enrichment analysis (GO and KEGG) and protein-protein interaction network construction. Five core proteins were validated in plasma samples from an additional 125 AMI patients and 120 healthy controls via enzyme-linked immunosorbent assay. To evaluate diagnostic performance, receiver operating characteristic curves were generated using GEO-related datasets, and Mendelian randomization analysis was employed to investigate the causal relationship between core proteins and AMI risk. Results: The study identified 32 proteins with significantly altered expression levels between AMI patients and healthy controls. Among these, five core proteins-PCOLCE, FCN2, REG1A, DEFA1, and CRTAC1-were significantly associated with key biological processes such as metabolism, collagen formation, and the PI3K/AKT signaling pathway. These proteins showed strong correlations with clinical indicators, including BMI, LVEF, NT-proBNP, CK-MB, and cTnT. FCN2 and DEFA1 were further validated as having a causal relationship with AMI risk, indicating their potential as diagnostic biomarkers. Conclusion: The identified core proteins PCOLCE, FCN2, REG1A, DEFA1, and CRTAC1 are potential biomarkers for the early diagnosis and risk assessment of AMI. These findings suggest that these proteins could serve as targets for future therapeutic interventions aimed at mitigating cardiovascular metabolic damage in AMI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/jir.s495784

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Differential Analysis of Control and AMI. (A) Flowchart of this study; (B) Visualization of clinical indicators between the CON and AMI groups in the Olink dataset. The size of each circle represents the strength of correlation, while the shade of blue indicates the absolute value of the correlation (darker blue reflects a stronger correlation); (C) Quality control box plot of the control and AMI groups; (D) Heatmap of differences between the control and AMI groups.
Figure 1 Differential Analysis of Control and AMI. (A) Flowchart of this study; (B) Visualization of clinical indicators between the CON and AMI groups in the Olink dataset. The size of each circle represents the strength of correlation, while the shade of blue indicates the absolute value of the correlation (darker blue reflects a stronger correlation); (C) Quality control box plot of the control and AMI groups; (D) Heatmap of differences between the control and AMI groups.CC BY-NC · PubMed Central
Figure 2 Analysis of up-regulated and down-regulated proteins in DEPs between Control and AMI group. (A) Visualization of up- and down-regulated DEPs; (B) Volcano plot of DEPs; (C) Heatmap of the top 19 differential proteins between control and AMI groups.
Figure 2 Analysis of up-regulated and down-regulated proteins in DEPs between Control and AMI group. (A) Visualization of up- and down-regulated DEPs; (B) Volcano plot of DEPs; (C) Heatmap of the top 19 differential proteins between control and AMI groups.CC BY-NC · PubMed Central
Figure 3 GO, KEGG, and PPI Analysis. (A) Bar chart of the top 30 GO differential analyses of DEPs; (B) Bar chart of DEPs KEGG analysis; (C) PPI analysis of the connections between DEPs.
Figure 3 GO, KEGG, and PPI Analysis. (A) Bar chart of the top 30 GO differential analyses of DEPs; (B) Bar chart of DEPs KEGG analysis; (C) PPI analysis of the connections between DEPs.CC BY-NC · PubMed Central
Figure 4 Correlation between Olink DEPs up-regulated proteins and clinical indicators. (A) Statistical analysis of DEPs up-regulated proteins between the control and AMI groups; (B) Visualization of the correlation between DEPs up-regulated proteins and clinical indicators. The network lines represent the direction and strength of the correlation (green for negative correlation, Orange for positive correlation), and the depth of color in the heatmap indicates the correlation coefficient value. Control: healthy individuals (n = 10). AMI: acute myocardial infarction patients (n = 20). Compared to the control group, **p < 0.01.
Figure 4 Correlation between Olink DEPs up-regulated proteins and clinical indicators. (A) Statistical analysis of DEPs up-regulated proteins between the control and AMI groups; (B) Visualization of the correlation between DEPs up-regulated proteins and clinical indicators. The network lines represent the direction and strength of the correlation (green for negative correlation, Orange for positive correlation), and the depth of color in the heatmap indicates the correlation coefficient value. Control: healthy individuals (n = 10). AMI: acute myocardial infarction patients (n = 20). Compared to the control group, **p < 0.01.CC BY-NC · PubMed Central
Figure 5 Clinical ELISA and external GEO dataset validation of DEPs up-regulated core proteins. (A) Statistical charts of ELISA validation for PCOLCE, FCN2, REG1A, DEFA1, and CRTAC1; (B-F) Expression levels and combined ROC curves of PCOLCE, FCN2, REG1A, DEFA1, and CRTAC1 in external GEO datasets GSE66360, GSE48060, GSE5406, GSE57388, and GSE57345. Control: healthy individuals (n = 120). AMI: acute myocardial infarction patients (n = 120). Compared to the control group, *p < 0.05, **p < 0.01.
Figure 5 Clinical ELISA and external GEO dataset validation of DEPs up-regulated core proteins. (A) Statistical charts of ELISA validation for PCOLCE, FCN2, REG1A, DEFA1, and CRTAC1; (B-F) Expression levels and combined ROC curves of PCOLCE, FCN2, REG1A, DEFA1, and CRTAC1 in external GEO datasets GSE66360, GSE48060, GSE5406, GSE57388, and GSE57345. Control: healthy individuals (n = 120). AMI: acute myocardial infarction patients (n = 120). Compared to the control group, *p < 0.05, **p < 0.01.CC BY-NC · PubMed Central
Figure 6 Results of Mendelian randomization studies. (A) Causal association between FCN2, DEFA1 and AMI. The bold numbers in the table indicate statistically significant results (p < 0.05). (B and C) Scatterplot: The x-axis shows the effect of SNPs on exposure, while the y-axis shows the effect of SNPs on the outcome. A positive slope indicates that the exposure factor adversely affects the outcome. (D and E) Forest plot: Values greater than 0 imply a positive association between the SNP and the outcome, whereas values less than 0 suggest a negative association. (F and G) Funnel plot. (H and I) Leave-one-out analysis: No instrumental variables were excluded, and the models’ effects remained statistically significant without significant deviations.
Figure 6 Results of Mendelian randomization studies. (A) Causal association between FCN2, DEFA1 and AMI. The bold numbers in the table indicate statistically significant results (p < 0.05). (B and C) Scatterplot: The x-axis shows the effect of SNPs on exposure, while the y-axis shows the effect of SNPs on the outcome. A positive slope indicates that the exposure factor adversely affects the outcome. (D and E) Forest plot: Values greater than 0 imply a positive association between the SNP and the outcome, whereas values less than 0 suggest a negative association. (F and G) Funnel plot. (H and I) Leave-one-out analysis: No instrumental variables were excluded, and the models’ effects remained statistically significant without significant deviations.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 8

Metadata

Authors
Tan, X., Wang, X., Xu, S., Zeng, Y., Zhang, G., Xu, A., Jiang, Y., Jiang, H., Song, Y., Fan, J., Fu, Y., Bo, X., Fan, H., & Zhou, Y.
Affiliations
  • Soochow University (CN)
  • First Affiliated Hospital of Zhengzhou University (CN)
  • Third People's Hospital of Hefei (CN)
Corresponding author
  • Fan, Huimin
  • Zhou, Yafeng
Venue
Journal of Inflammation Research
Published
2025-02
Volume
Volume 18
Pages
2629-2646
ISSN
1178-7031 (ISSN-L)
OpenAlex
W4407810609
Cited by
8
References
36
Citations by year
2026: 6 · 2025: 2
FWCI
5.59
Type
journal article
Language
en
Open access
Locations
  • Journal of Inflammation Research (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (acceptedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Keywords
acute myocardial infarction, DEFA1, REG1A, CRTAC1, PI3K/Akt signaling, early diagnosis, risk assessment, Mendelian randomization, NT-proBNP, cTnT

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.